SECURITIES PURCHASE AGREEMENT among AMERICAN BUSINESS HOLDINGS, INC. as Issuer, Tong Liu, as Chairman and THE PERSONS LISTED ON THE SIGNATURE PAGES HERETO as Purchasers April __, 2008
EXHIBIT 10.2
among
as
Issuer,
Xxxx
Xxx,
as
Chairman
and
THE
PERSONS LISTED ON THE SIGNATURE PAGES HERETO
as
Purchasers
April
__, 2008
This
Securities Purchase Agreement (this “Agreement”) is dated
as of April __, 2008 among American Business Holdings, Inc., a
Delaware corporation (the “Issuer”), Xxxx Xxx (the “Chairman”) and each
purchaser identified on the signature pages hereto (each, including its
successors and assigns, a “Purchaser” and
collectively the “Purchasers”).
WHEREAS,
the Purchasers have agreed to purchase, and the Issuer has agreed to sell, the
Securities (as defined herein) in connection with the Purchasers’ agreement to
provide financing to the Issuer in the amount of U.S. $2,000,000;
WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to
Regulation D under the U.S. Securities Act of 1933, as amended (the “Act”) upon issuance
thereof, and until such time as the same is no longer required under the
applicable requirements of the Securities Act, the Common Stock, Warrants and
the Warrant Shares (as such terms are defined herein) shall bear the legends
relating to the offer and the sale of the Common Stock, Warrants and the Warrant
Shares as required by (i) Regulation D under the Securities Act or (ii) any
other applicable laws or regulations relating to the issuance of the
Securities.
NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement,
and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Issuer and each Purchaser agree as
follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions. In
addition to the terms defined elsewhere in this Agreement the following terms
have the meanings set forth in this Section 1.1:
“Action” has the
meaning ascribed to such term in Section 3.1(j).
“Affiliate” means any
Person that, directly or indirectly through one or more intermediaries, controls
or is controlled by or is under common control with a Person, as such terms are
used in and construed under Rule 405 under the Securities Act. With
respect to a Purchaser, any investment fund or managed account that is managed
on a discretionary basis by the same investment manager as such Purchaser will
be deemed to be an Affiliate of such Purchaser.
“Business Day” means
any day except Saturday, Sunday, any day which is a federal legal holiday in the
United States or any day on which banking institutions in the State of New York
are authorized or required by law or other governmental action to
close.
“Chairman” has the
meaning ascribed to such term in the first paragraph.
“Shell” has the
meaning ascribed to such term in Section 2.3(b).
2
“Closing” means the
closing of the purchase and sale of the Securities pursuant to Section
2.1.
“Closing Date” means
the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties thereto, and all conditions precedent to (i)
the Purchasers’ obligations to pay the Subscription Amount and (ii) the Issuer’s
obligations to deliver the Securities have been satisfied or
waived.
“Commission” means the
Securities and Exchange Commission.
“Common Stock” means
the common stock of the Issuer, par value $0.001 per share, and any other class
of securities into which such securities may hereafter be reclassified or
changed.
“Common Stock
Equivalents” means any securities of the Issuer or the Subsidiaries which
would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, rights, options, warrants or
other instrument that is at any time convertible into or exercisable or
exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.
“Corporate Authorization
Documents” means (i) the resolutions of the Board of Directors of the
Issuer, in form and substance satisfactory to the
Purchasers, authorizing the transactions contemplated herein,
including, without limitation, the issuance of the Common Stock and the Warrants
and the execution and delivery of the remaining Transaction Documents (ii) a
certificate of the Secretary of the Issuer in usual and customary form attesting
to the copies of the certificate of incorporation and bylaws of the Issuer
attached thereto.
“Disclosure Schedules”
has the meaning ascribed to such term in Section 3.1.
“Effective Date” means
the date that the initial Registration Statement filed by the Issuer pursuant to
the Registration Rights Agreement is first declared effective by the
Commission.
“Escrow Agent” means
Xxxxx Rozynko LLP.
“Escrow Agreement”
means the escrow agreement entered into on the date hereof, by and among the
Issuer, the Issuer’s management, the Purchasers and the Escrow Agent pursuant to
which the Issuer’s management shall deliver into an escrow account, an aggregate
number of common shares owned by them equal to one hundred (100%) percent of the
shares issued to the Purchasers to be applied to the transactions contemplated
hereunder, in the form of Exhibit A attached
hereto.
“Exchange Act” means
the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder.
3
“Fundamental
Transaction” means any of the following actions or agreements by the
Issuer or any Subsidiary: (i) a merger or consolidation in which the Issuer is
not the surviving entity or the shareholders (or owners of registered capital or
other form of ownership) of the Issuer or its Subsidiary are not the controlling
shareholders after such transaction (ii) a sale of all or substantially all of
the assets of the Issuer or any Subsidiary, as the case may be, or (iii) the
sale of any of the legal and beneficial ownership of any
Subsidiary.
“GAAP” has the meaning
ascribed to such term in Section 3.1(h).
“Intellectual Property
Rights” has the meaning ascribed to such term in Section
3.1(o).
“Legend Removal Date”
has the meaning ascribed to such term in Section 4.1(d).
“Liens” means a lien,
charge, security interest, encumbrance, right of first refusal, preemptive right
or other restriction.
“Lock-Up” means the
several lock-up agreements entered into on the date hereof, by and among the
Issuer and its existing shareholders pursuant to which the shareholders will be
locked up until twelve (12) months after the Closing Date, in the form of Exhibit D attached
hereto.
“Material Adverse
Effect” has the meaning assigned to such term in Section
3.1(b).
“Material Permits” has
the meaning ascribed to such term in Section 3.1(m).
“Person” means an
individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company,
government (or an agency or subdivision thereof) or other entity of any
kind.
“Pre-Notice” has the
meaning ascribed to such term in Section 4.12(b).
“PRC” means the
People’s Republic of China.
“Proceeding” means an
action, claim, suit, investigation or proceeding (including, without limitation,
an informal investigation or partial proceeding, such as a deposition), whether
commenced or threatened.
“Purchaser’s Counsel”
means Xxxxx Rozynko LLP, with offices located at 000 Xxxxxxxxxx Xxxxxx, Xxxxx
0000, Xxx Xxxxxxxxx, Xxxxxxxxxx, 00000.
“Purchaser Party” has
the meaning ascribed to such term in Section 4.10.
4
“Registration Rights
Agreement” means the Registration Rights Agreement, dated the date
hereof, among the Issuer and the Purchasers, in the form of Exhibit B attached
hereto.
“Registration
Statement” means a registration statement meeting the requirements set
forth in the Registration Rights Agreement and covering the resale of the
Underlying Shares by each Purchaser as provided for in the Registration Rights
Agreement.
“Required Approvals”
has the meaning ascribed to such term in Section 3.1(e).
“Rule 144” means Rule
144 promulgated by the Commission pursuant to the Securities Act, as such Rule
may be amended from time to time, or any similar rule or regulation hereafter
adopted by the Commission having substantially the same effect as such
Rule.
“SEC Reports” shall
have the meaning ascribed to such term in Section 3.1(h).
“Securities” means the
Common Stock, Warrants and the Underlying Shares.
“Securities Act” means
the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder.
“Short Sales” means
all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange
Act (but shall not be deemed to include the location and/or reservation of
borrowable shares of Common Stock).
“Subscription Amount”
means, as to each Purchaser, the aggregate amount to be paid for Shares and
Warrants purchased hereunder as specified below such Purchaser’s name on the
signature page of this Agreement and next to the heading “Subscription Amount,”
in United States dollars and in immediately available funds.
“Subsequent Financing”
has the meaning ascribed to such term in Section 4.12.
“Subsequent Financing
Notice” has the meaning ascribed to such term in Section
4.13.
“Subsidiary” means any
subsidiary of the Issuer as set forth on Schedule 3.1(a) and
shall, where applicable, include any direct or indirect subsidiary of the Issuer
formed or acquired after the date hereof.
“Trading Day” means a
day on which the New York Stock Exchange is open for trading.
“Trading Market” means
the following markets or exchanges on which the Common Stock is listed or quoted
for trading on the date in question: the American Stock Exchange, the Nasdaq
Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange or the OTC Bulletin Board.
5
“Transaction
Documents” means this Agreement, the Warrants, the Registration Rights
Agreement, the Escrow Agreement, the Lock-Up and all exhibits and schedules
thereto and hereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.
“Transfer Agent” means
Interest Transfer Company, Inc. with a mailing address of 0000 Xxxx Xxxxxx
Xxxxxxxx Xxxx, Xxxxx 000, Xxxx Xxxx Xxxx, XX 00000 and a facsimile number of
(000) 000-0000 and any successor transfer agent of the Issuer.
“Underlying Shares”
means the shares of Common Stock issued and issuable upon exercise of the
Warrants.
“VWAP” means, for any
date, the price determined by the first of the following clauses that applies:
(a) if the Common Stock is then listed or quoted on a Trading Market, the daily
volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed
or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m.
New York City time to 4:02 p.m. New York City time); (b) if the OTC
Bulletin Board is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on the OTC Bulletin
Board; (c) if the Common Stock is not then listed or quoted on the OTC Bulletin
Board and if prices for the Common Stock are then reported in the “Pink Sheets”
published by Pink Sheets, LLC (or a similar organization or agency succeeding to
its functions of reporting prices), the most recent bid price per share of the
Common Stock so reported; or (d) in all other cases, the fair market value
of a share of Common Stock as determined by an independent appraiser selected in
good faith by the Purchasers of a majority in interest of the Securities then
outstanding and reasonably acceptable to the Issuer, the fees and expenses of
which shall be paid by the Issuer.
“Warrants” means the
Common Stock warrants to purchase an aggregate of 2,000,000 shares of the Issuer
with an exercise price of U.S. $1.25 per share and substantially in the form of
Exhibit C
hereto.
ARTICLE
II.
PURCHASE
AND SALE
2.1 Closing.
(a) On
the Closing Date, upon the terms and subject to the conditions set forth herein,
substantially concurrent with the execution and delivery of this Agreement by
the parties hereto, the Issuer agrees to sell, and the Purchasers, severally and
not jointly, agree to purchase, in the aggregate, up to $2,000,000 in principal
amount of the Shares and the Warrants. Each Purchaser shall deliver
to the Issuer, via wire transfer or a certified check, immediately available
funds equal to its Subscription Amount to the account as specified by the Issuer
and the Issuer shall deliver to each Purchaser its respective certificates for
shares of Common Stock and the respective Warrants, and the Issuer and each
Purchaser shall deliver the other items set forth in Section 2.2 deliverable at
the Closing. Upon satisfaction of the conditions set forth in Section
2.3, the Closing shall occur at the offices of Purchaser’s Counsel or such
6
other
location or via email and facsimile as the parties shall mutually
agree.
(b) Allocation of Purchase
Price. The Issuer and its independent auditors shall confirm the amount
of the aggregate purchase price of $2,000,000 allocated by the Issuer to each of
the Shares and the Warrants and shall provide the Purchasers with such
determination. The allocation shall be made in accordance with United States
GAAP.
2.2 Deliveries.
(a) On
the Closing Date, the Issuer shall deliver or cause to be delivered to each
Purchaser the following:
(i)
|
this
Agreement duly executed by the
Issuer;
|
(ii)
|
a
Warrant certificate for the number of shares of Common Stock in an amount
equal to such Purchaser’s Subscription Amount, registered in the name of
such Purchaser;
|
(iii)
|
the
Registration Rights Agreement duly executed by the
Issuer;
|
(iv)
|
the
Escrow Agreement and the certificate(s) for the shares subject thereto
together with and at least one undated stock power signature medallion
guaranteed for each share
certificate;
|
(v)
|
the
Corporate Authorization Documents;
and
|
(vi)
|
the
Lock-Up.
|
(b) Within
five (5) days of the Closing Date, the Issuer shall deliver or cause to be
delivered to each Purchaser the following:
(i)
|
a
certificate for shares of Common Stock in an amount equal to such
Purchaser’s Subscription Amount, registered in the name of such
Purchaser.
|
(c) On
the Closing Date, each Purchaser shall deliver or cause to be delivered to the
Issuer the following:
(i)
|
this
Agreement duly executed by such
Purchaser;
|
(ii)
|
such
Purchaser’s Subscription Amount by wire transfer to theEscrow account as
specified in writing by the Issuer;
and
|
(iiii)
|
the
Registration Rights Agreement duly executed by
suchPurchaser
|
7
2.3 Closing
Conditions.
(a) The
obligations of the Issuer hereunder in connection with the Closing are subject
to the following conditions being met:
(i)
|
the
accuracy in all material respects on the Closing Date of
therepresentations and warranties of the Purchasers contained
herein;
|
(ii)
|
all
obligations, covenants and agreements of each Purchaserrequired to be
performed at or prior to the Closing Date shall havebeen performed;
and
|
(iii)
|
the
delivery by each Purchaser of the items set forth in Section 2.2(b) of
this
Agreement.
|
(b) The
respective obligations of the Purchasers hereunder in connection with the
Closing are subject to the following conditions being met:
(i)
|
the
accuracy in all material respects when made and on the ClosingDate of the
representations and warranties of the Issuercontained
herein;
|
(ii)
|
all
obligations, covenants and agreements of the Issuer requiredto be
performed at or prior to the Closing Date shall have
beenperformed;
|
(iii)
|
the
delivery by the Issuer of the items set forth in Section2.2(a) of this
Agreement;
|
(iv)
|
there
shall have been no Material Adverse Effect with respect to the Issuer
since the date hereof;
|
(v)
|
simultaneously
on the Closing Date, the Issuer shall have completed a transaction
involving the acquisition of a Cayman Island Holding Company, which has
the rights to the Issuer’s business and properties into a publicly traded
shell (the “Shell”) listed
on a Trading Market; the Purchasers reserve the right to approve the
Shell; and
|
(vi)
|
from
the date hereof to the Closing Date, and, at any time prior to the Closing
Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been
established on securities whose trades are reported by such service, or on
any Trading Market, nor shall a banking moratorium have been declared
either by the United States or New York State authorities nor shall there
have occurred any material outbreak or escalation of hostilities or other
national or international calamity of such magnitude in its effect on, or
any material adverse change in, any financial market which, in each case,
in the reasonable judgment of each Purchaser, makes it impracticable or
inadvisable to purchase the Securities at the
Closing.
|
8
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1 Representations and
Warranties of the Issuer. For purposes of this Article III,
the term the “Issuer” shall be deemed to include the Issuer and each
Subsidiary. Except as set forth in the Disclosure Schedules which
Disclosure Schedules shall be deemed a part hereof and shall qualify any
representation or otherwise made herein to the extent of the disclosure
contained in the corresponding section of the Disclosure Schedules, the Issuer
hereby makes the following representations and warranties to each
Purchaser:
(a) Subsidiaries. All
of the direct and indirect Subsidiaries of the Issuer are set forth on Schedule
3.1(a). The Issuer owns, directly or indirectly, all of the
capital stock or other equity interests of each Subsidiary free and clear of any
Liens, and all of the issued and outstanding shares of capital stock of each
Subsidiary are validly issued and are fully paid, non-assessable and free of
preemptive and similar rights to subscribe for or purchase
securities.
(b) Organization and
Qualification. The Issuer and each of the Subsidiaries is an
entity duly incorporated or otherwise organized, validly existing and in good
standing under the laws of the jurisdiction of its incorporation or organization
(as applicable), with the requisite power and authority to own and use its
properties and assets and to carry on its business as currently
conducted. Neither the Issuer nor any Subsidiary is in violation or
default of any of the provisions of its respective certificate or articles of
incorporation, bylaws or other organizational or charter
documents. Each of the Issuer and the Subsidiaries is duly qualified
to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary, except where the
failure to be so qualified or in good standing, as the case may be, could not
have or reasonably be expected to result in (i) a material adverse effect on the
legality, validity or enforceability of any Transaction Document, (ii) a
material adverse effect on the results of operations, assets, business,
prospects or condition (financial or otherwise) of the Issuer and the
Subsidiaries, taken as a whole, or (iii) a material adverse effect on the
Issuer’s ability to perform in any material respect on a timely basis its
obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse
Effect”) and no Proceeding has been instituted in any such jurisdiction
revoking, limiting or curtailing or seeking to revoke, limit or curtail such
power and authority or qualification.
9
(c) Authorization;
Enforcement. The Issuer has the requisite corporate power and
authority to enter into and to consummate the transactions contemplated by each
of the Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of each of the
Transaction Documents by the Issuer and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all
necessary action on the part of the Issuer and no further action is required by
the Issuer, its board of directors or its stockholders in connection therewith
other than in connection with the Required Approvals. Each
Transaction Document has been (or upon delivery will have been) duly executed by
the Issuer and, when delivered in accordance with the terms hereof and thereof,
will constitute the valid and binding obligation of the Issuer enforceable
against the Issuer in accordance with its terms except (i) as limited by general
equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of
creditors’ rights generally, (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be
limited by applicable law.
(d) No
Conflicts. The execution, delivery and performance of the
Transaction Documents by the Issuer and the consummation by the Issuer of the
other transactions contemplated hereby and thereby do not and will not: (i)
conflict with or violate any provision of the Issuer’s or any Subsidiary’s
certificate or articles of incorporation, bylaws or other organizational or
charter documents, or (ii) conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, result
in the creation of any Lien upon any of the properties or assets of the Issuer
or any Subsidiary, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of,
any agreement, credit facility, debt or other instrument (evidencing a Issuer or
Subsidiary debt or otherwise) or other understanding to which the Issuer or any
Subsidiary is a party or by which any property or asset of the Issuer or any
Subsidiary is bound or affected, or (iii) subject to the Required Approvals,
conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental
authority to which the Issuer or a Subsidiary is subject (including federal and
state securities laws and regulations), or by which any property or asset of the
Issuer or a Subsidiary is bound or affected; except in the case of each of
clauses (ii) and (iii), such as could not have or reasonably be expected to
result in a Material Adverse Effect.
(e) Filings, Consents and
Approvals. The Issuer is not required to obtain any consent,
waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution,
delivery and performance by the Issuer of the Transaction Documents, other than
(i) filings required pursuant to Section 4.7, (ii) and the filing with the
Commission of the Registration Statement (collectively, the “Required
Approvals”).
10
(f) Issuance of the
Securities. The Securities are duly authorized and, when
issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Issuer other than restrictions on transfer provided for
in the Transaction Documents. The Underlying Shares, when issued in
accordance with the terms of the Transaction Documents, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the Issuer
other than restrictions on transfer provided for in the Transaction
Documents. The Issuer has reserved from its duly authorized capital
stock a number of shares of Common Stock for issuance of the Underlying
Shares.
(g) Capitalization. The
capitalization of the Issuer is as set forth on Schedule 3.1(g),
which Schedule
3.1(g) shall also include the number of shares of Common Stock owned
beneficially, and of record, by Affiliates of the Issuer as of the date hereof.
The Issuer has not issued any capital stock since its most recently audited
financial statements. No Person has any right of first refusal,
preemptive right, right of participation, or any similar right to participate in
the transactions contemplated by the Transaction Documents. Except as
a result of the purchase and sale of the Securities, there are no outstanding
options, warrants, scrip rights to subscribe to, calls or commitments of any
character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any
right to subscribe for or acquire, any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Issuer or any
Subsidiary is or may become bound to issue additional shares of Common Stock or
Common Stock Equivalents. The issuance and sale of the Securities will not
obligate the Issuer to issue shares of Common Stock or other securities to any
Person (other than the Purchasers) and will not result in a right of any holder
of Issuer securities to adjust the exercise, conversion, exchange or reset price
under any of such securities. All of the outstanding shares of capital stock of
the Issuer are validly issued, fully paid and nonassessable, have been issued in
compliance with all federal and state securities laws, and none of such
outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. No further approval
or authorization of any stockholder, the Board of Directors of the Issuer or
others is required for the issuance and sale of the Securities. There
are no stockholders agreements, voting agreements or other similar agreements
with respect to the Issuer’s capital stock to which the Issuer is a party or, to
the knowledge of the Issuer, between or among any of the Issuer’s
stockholders.
(h) SEC Reports; Financial
Statements. The Shell has filed all reports, schedules, forms,
statements and other documents required to be filed by the Shell under the
Securities Act and the Exchange Act, including pursuant to Section 13(a) or
15(d) thereof, for the two years preceding the date hereof (or such shorter
period as the Shell was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents
incorporated by reference therein, being collectively referred to herein as the
“SEC Reports”)
on a timely basis or has received a valid extension of such time of filing and
has filed any such SEC Reports prior to the expiration of any such
extension.
11
As of
their respective dates, the SEC Reports complied in all material respects with
the requirements of the Securities Act and the Exchange Act, as applicable, and
none of the SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The
financial statements of the Shell included in the SEC Reports comply in all
material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of
filing. Such financial statements and the audited financial
statements of the Issuer for fiscal year ending December 31, 2007 and 2006 have
been prepared in accordance with United States generally accepted accounting
principles applied on a consistent basis during the periods involved (“GAAP”), except as may
be otherwise specified in such financial statements or the notes thereto and
except that unaudited financial statements may not contain all footnotes
required by GAAP, and fairly present in all material respects the financial
position of the Shell and the Issuer, as the case may be, and their consolidated
subsidiaries as of and for the dates thereof and the results of operations and
cash flows for the periods then ended, subject, in the case of unaudited
statements, to normal, immaterial, year-end audit adjustments.
(i) Material
Changes. Since the date of the audited financial statements of
the Issuer for fiscal year ending December 31, 2007, (i) there has been no
event, occurrence or development that has had or that could reasonably be
expected to result in a Material Adverse Effect, (ii) the Issuer has not
incurred any liabilities (contingent or otherwise) other than (A) trade payables
and accrued expenses incurred in the ordinary course of business consistent with
past practice and (B) liabilities not required to be reflected in the Issuer’s
financial statements pursuant to GAAP, (iii) the Issuer has not altered its
method of accounting, (iv) the Issuer has not declared or made any dividend or
distribution of cash or other property to its stockholders or purchased,
redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v) the Issuer has not issued any equity securities to any officer,
director or Affiliate, (except pursuant to existing Issuer stock option
plans).
(j) Litigation. Other
than as disclosed on Schedule 3.1(j) there is no action, suit, inquiry, notice
of violation, proceeding or investigation pending or, to the knowledge of the
Issuer, threatened against or affecting the Issuer, any Subsidiary or any of
their respective properties before or by any court, arbitrator, governmental or
administrative agency or regulatory authority (federal, state, county, local or
foreign) (collectively, an “Action”) which (i)
adversely affects or challenges the legality, validity or enforceability of any
of the Transaction Documents or the Securities or (ii) could, if there were an
unfavorable decision, have or reasonably be expected to result in a Material
Adverse Effect. Neither the Issuer nor any Subsidiary, nor any
director or officer thereof, is or has been the subject of any Action involving
a claim of violation of or liability under federal or state securities laws or a
claim of breach of fiduciary duty. There has not been, and to the
knowledge of the Issuer, there is not pending or contemplated, any investigation
by the Commission involving the Issuer or any current or former director or
officer of the Issuer.
(k) Labor
Relations. No material labor dispute exists or, to the
knowledge of the Issuer, is imminent with respect to any of the employees of the
Issuer which could reasonably be expected to result in a Material Adverse
Effect.
12
None of
the Issuer’s or its Subsidiaries’ employees is a member of a union that relates
to such employee’s relationship with the Issuer or such Subsidiary, and neither
the Issuer nor any of its Subsidiaries is a party to a collective bargaining
agreement, and the Issuer and its Subsidiaries believe that their relationships
with their employees are good. No executive officer, to the knowledge
of the Issuer, is, or is now expected to be, in violation of any material term
of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or
agreement or any restrictive covenant in favor of any third party, and the
continued employment of each such executive officer does not subject the Issuer
or any of its Subsidiaries to any liability with respect to any of the foregoing
matters. The Issuer and its Subsidiaries are in compliance with all
U.S. federal, state, local and foreign laws and regulations relating to
employment and employment practices, terms and conditions of employment and
wages and hours, except where the failure to be in compliance could not,
individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect.
(l) Compliance. Neither
the Issuer nor any Subsidiary (i) is in default under or in violation of (and no
event has occurred that has not been waived that, with notice or lapse of time
or both, would result in a default by the Issuer or any Subsidiary under), nor
has the Issuer or any Subsidiary received notice of a claim that it is in
default under or that it is in violation of, any indenture, loan or credit
agreement or any other agreement or instrument to which it is a party or by
which it or any of its properties is bound (whether or not such default or
violation has been waived), (ii) is in violation of any order of any court,
arbitrator or governmental body, or (iii) is or has been in violation of any
statute, rule or regulation of any governmental authority, including without
limitation all foreign, federal, state and local laws applicable to its business
and all such laws that affect the environment, except in each case as could not
have or reasonably be expected to result in a Material Adverse
Effect.
(m) Regulatory
Permits. The Issuer and the Subsidiaries possess all
certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their
respective businesses, except where the failure to possess such permits could
not reasonably be expected to result in a Material Adverse Effect (“Material Permits”),
and neither the Issuer nor any Subsidiary has received any notice of proceedings
relating to the revocation or modification of any Material Permit. Schedule
3.1(m) sets forth a complete list of all permits and licenses and regulatory
approvals required by the subsidiaries to operate their respective business in
the PRC, each of which has been obtained and has not been revoked or
amended. The Issuer and its Subsidiaries have paid all fees for
permits and licenses required to be paid by them in the PRC in connection with
the operation of their respective businesses.
(n) Title to
Assets. The Issuer and the Subsidiaries have good and
marketable title in fee simple to all real property owned by them and good and
marketable title in all personal property owned by them that is material to the
business of the Issuer and the Subsidiaries, in each case free and clear of all
Liens, except for Liens as do not materially affect the value of such property
and do not materially interfere with the use made and proposed to be made of
such property by the Issuer and the Subsidiaries and Liens for the payment of
PRC, federal, state or other taxes, the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under
lease by the Issuer and the Subsidiaries are held by them under valid,
subsisting and enforceable leases with which the Issuer and the Subsidiaries are
in compliance in all respects.
13
(o) Patents and
Trademarks. The Issuer and the Subsidiaries have, or have
rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights,
licenses and other intellectual property rights and similar rights necessary or
material for use in connection with their respective businesses and which the
failure to so have could have a Material Adverse Effect (collectively, the
“Intellectual Property
Rights”). Neither the Issuer nor any Subsidiary has received a
notice (written or otherwise) that any of the Intellectual Property Rights used
by the Issuer or any Subsidiary violates or infringes upon the rights of any
Person. To the knowledge of the Issuer, all such Intellectual Property Rights
are enforceable and there is no existing infringement by another Person of any
of the Intellectual Property Rights. The Issuer and its Subsidiaries
have taken reasonable security measures to protect the secrecy, confidentiality
and value of all of their intellectual properties, except where failure to do so
could not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.
(p) Insurance. The
Issuer and the Subsidiaries have no insurance against losses and risks
including, but not limited to, directors and officers insurance
coverage. Neither the Issuer nor any Subsidiary has any reason to
believe that it will not be able to obtain such coverage from insurers as may be
necessary to continue its business.
(q) Transactions with Affiliates
and Employees. Except as contemplated by this Agreement, none
of the officers or directors of the Issuer and, to the knowledge of the Issuer,
none of the employees of the Issuer is presently a party to any transaction with
the Issuer or any Subsidiary (other than for services as employees, officers and
directors), including any contract, agreement or other arrangement providing for
the furnishing of services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments to or from any officer,
director or such employee or, to the knowledge of the Issuer, any entity in
which any officer, director, or any such employee has a substantial interest or
is an officer, director, trustee or partner, in each case in excess of $10,000
other than for (i) payment of salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the Issuer and (iii) other
employee benefits, including stock option agreements under any stock option plan
of the Issuer.
(r) Internal
Controls. The Issuer maintains a system of internal accounting
controls sufficient to provide reasonable assurance that (i) transactions
are executed in accordance with management’s general or specific authorization,
(ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii)
access to assets is permitted only in accordance with management’s general or
specific authorization and (iv) the recorded accountability for assets is
compared with the existing assets at quarterly intervals and appropriate action
is taken with respect to any material differences.
14
(s) Certain
Fees. Other than as described on Schedule 3.1(s) no brokerage
or finder’s fees or commissions are or will be payable by the Issuer to any
broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by
the Transaction Documents. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of
other Persons for fees of a type contemplated in this Section that may be due in
connection with the transactions contemplated by the Transaction
Documents.
(t) Private
Placement. Assuming the accuracy of the Purchasers’
representations and warranties set forth in Section 3.3, no registration under
the Securities Act is required for the offer and sale of the Securities by the
Issuer to the Purchasers as contemplated hereby.
(u) Investment Company.
The Issuer is not, and is not an Affiliate of, and immediately after receipt of
payment for the Securities, will not be or be an Affiliate of, an “investment
company” within the meaning of the Investment Company Act of 1940, as
amended. The Issuer shall conduct its business in a manner so that it
will not become subject to the Investment Company Act of 1940, as
amended.
(v) Registration
Rights. Other than each of the Purchasers, no Person has any
right to cause the Issuer to effect the registration under the Securities Act of
any securities of the Issuer.
(w) Leases. The
Issuer and each Subsidiary is in compliance with the terms and conditions of all
of its material contracts and leases, and is not aware of any dispute or
disagreement with the other parties or their Affiliates regarding such contracts
or leases. The Issuer is not aware of, and has not received any notice of
(whether written or oral) or any disputes, defaults or claims under such
contracts or leases.
(x) Application of Takeover
Protections. The Issuer and its board of directors have taken
all necessary action, if any, in order to render inapplicable any control share
acquisition, business combination, poison pill (including any distribution under
a rights agreement) or other similar anti-takeover provision under the Issuer’s
certificate of incorporation (or similar charter documents) or the laws of its
state of incorporation that is or could become applicable to the Purchasers as a
result of the Purchasers and the Issuer fulfilling their obligations or
exercising their rights under the Transaction Documents, including without
limitation as a result of the Issuer’s issuance of the Securities and the
Purchasers’ ownership of the Securities.
(y) Disclosure. Except
with respect to the material terms and conditions of the transactions
contemplated by the Transaction Documents, the Issuer confirms that neither it
nor any other Person acting on its behalf has provided any of the Purchasers or
their agents or counsel with any information that it believes constitutes or
might constitute material, nonpublic information.
15
The
Issuer understands and confirms that the Purchasers will rely on the foregoing
representation in effecting transactions in securities of the
Issuer. All disclosure furnished by or on behalf of the Issuer to the
Purchasers regarding the Issuer, its business and the transactions contemplated
hereby, including the Disclosure Schedules to this Agreement, is true and
correct and does not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements made therein,
in light of the circumstances under which they were made, not
misleading. The press releases disseminated by the Issuer
during the twelve months preceding the date of this Agreement taken as a whole
do not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made and
when made, not misleading. The Issuer acknowledges and agrees that no
Purchaser makes or has made any representations or warranties with respect to
the transactions contemplated hereby other than those specifically set forth in
Section 3.3 hereof.
(z) No Integrated
Offering. Assuming the accuracy of the Purchasers’ representations and
warranties set forth in Section 3.3, neither the Issuer, nor any of its
Affiliates, nor any Person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to
buy any security, under circumstances that would cause this offering of the
Securities to be integrated with prior offerings by the Issuer for purposes of
the Securities Act which would require the registration of any such securities
under the Securities Act.
(aa) Exemption from
Registration. Subject to the accuracy of the Purchaser’s representations
and warranties set forth in Section 3.3, except as required pursuant to the
Registration Rights Agreement, the sale of the Common Stock and Warrants by the
Issuer to the Purchaser will not require registration under the Securities Act,
but may require registration under New York state securities law if applicable
to the Purchaser. The Issuer is issuing the Common Stock
and the Warrants in accordance with and in reliance upon the exemption from
securities registration afforded, inter alia, by Rule 506 under Regulation D as
promulgated by the Commission under the Securities Act, and/or Section 4(2) of
the Securities Act; provided, however, that certain filings and registrations
may be required under state securities “blue sky” laws depending upon the
residency of the Purchaser.
(bb) No General
Solicitation. Neither the Issuer nor any of its Affiliates, or any person
acting on its or their behalf, directly or indirectly, (i) has conducted or will
conduct any general solicitation (as that term is used in Rule 502(c) of
Regulation D as promulgated by the Commission under the Securities Act) or
general advertising with respect to the sale of the Common Stock or Warrants, or
(ii) made any offers or sales of any security or solicited any offers to buy any
security under any circumstances that would require registration of the Common
Stock or Warrants, under the Securities Act, except as required
herein.
16
(cc) Foreign Corrupt
Practices. Neither the Issuer, nor to the knowledge of the
Issuer, any agent or other person acting on behalf of the Issuer, has (i)
directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic
political activity, (ii) made any unlawful payment to foreign or domestic
government officials or employees or to any foreign or domestic political
parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Issuer (or made by any person acting on its behalf of
which the Issuer is aware) which is in violation of law, or (iv)
violated in any material respect any provision of the Foreign Corrupt Practices
Act of 1977, as amended.
(dd) Accountants. The
Issuer’s accounting firm is set forth on Schedule 3.1(dd) of
the Disclosure Schedule. To the knowledge and belief of the Issuer,
such accounting firm is a registered public accounting firm as required by the
Exchange Act. If the accounting firm set forth on Schedule 3.1(dd) of
the Disclosure Schedule is not now, or in the future fails to be, a registered
public accounting firm as required by the Exchange Act, such accounting firm
will be replace immediately with an accounting firm that is a registered public
accounting firm as required by the Exchange Act.
(ee) No Disagreements with
Accountants and Lawyers. There are no disagreements of any
kind presently existing, or reasonably anticipated by the Issuer to arise,
between the Issuer and the accountants and lawyers formerly or presently
employed by the Issuer and the Issuer is current with respect to any fees owed
to its accountants and lawyers which could affect the Issuer’s ability to
perform any of its obligations under any of the Transaction
Documents.
(ff) Tax
Status. Except for matters that would not, individually or in
the aggregate, have or reasonably be expected to result in a Material Adverse
Effect, the Issuer and each Subsidiary has filed all necessary federal, state
and foreign income and franchise tax returns (including, without limitation, all
PRC tax returns and filings) and has paid or accrued all taxes shown as due
thereon, has paid all PRC taxes and the Issuer has no knowledge of a tax
deficiency which has been asserted or threatened against the Issuer or any
Subsidiary. The Issuer warrants that the transactions contemplated by
the Transaction Documents will not subject the Issuer or its subsidiaries to
U.S. taxation or require the Issuer to deem income in any material amount from
its subsidiaries to be subject to U.S. taxation.
(gg) Acknowledgment Regarding
Purchasers’ Purchase of Securities. The Issuer acknowledges
and agrees that each of the Purchasers is acting solely in the capacity of an
arm’s length purchaser with respect to the Transaction Documents and the
transactions contemplated thereby. The Issuer further acknowledges
that no Purchaser is acting as a financial advisor or fiduciary of the Issuer
(or in any similar capacity) with respect to the Transaction Documents and the
transactions contemplated thereby and any advice given by any Purchaser or any
of their respective representatives or agents in connection with the Transaction
Documents and the transactions contemplated thereby is merely incidental to the
Purchasers’ purchase of the Securities. The Issuer further represents
to each Purchaser that the Issuer’s decision to enter into this Agreement and
the other Transaction Documents has been based solely on the independent
evaluation of the transactions contemplated hereby by the Issuer and its
representatives.
17
(hh) Sovereign
Immunity. Under the laws of their respective jurisdiction of
incorporation and the PRC, neither the Issuer nor any Subsidiary, is, nor
are any of their respective properties, assets or
revenues, entitled to any right of immunity on the grounds of
sovereignty from any legal action, suit or proceeding, from set-off or
counterclaim, from the jurisdiction of any court, from service of process, from
attachment prior to or in aid of execution of judgment, or from other legal
process or proceeding for the giving of any relief or for the enforcement of any
judgment.
(ii) Environmental Law
Compliance
(i) The
Issuer and each of its Subsidiaries has at all times complied with all
environmental legislation in force, relevant or applicable to each company,
whether in the PRC or elsewhere (the “Environmental
Legislation”) and there is nothing in, on, or under the Property (as
defined below) upon which the presence, existence or condition of which
constitutes a breach of such Environmental Legislation nor is there or has there
been any manufacturing, storage, generation, servicing, treatment, disposal or
other process carried on at the Property in such a way as to amount to a breach
of the same.
(ii) No
complaints have been received from any third party (includingany employee of any
of the Issuer and/or its Subsidiaries or governmental, regulatory,supervisory
oradministrative body) with regard to any breach of the Environmental
Legislation in connection with the Property and the development and construction
thereon and, after due and careful enquiry, the Issuer is not aware of any
events, circumstances or matters which may lead to such complaint.
(iii) No
toxic industrial waste or toxic substance (as defined in
anyEnvironmental Legislation) or any other similar substance
(howsoever termed) has beensplit, released, discharged or disposed in the soil
or water in, under, around or upon the Property.
For purposes of this clause, the term
“Property”
shall mean any and all locations in which the Issuer and/or each of its
Subsidiaries carry on their respective business operations.
(jj) PFIC. The
Issuer is not nor intends to become a “passive foreigninvestment company” (a
“PFIC”) within
the meaning of Section 1297 of the InternalRevenue Code.
(kk) Money Laundering
Laws. The operations of the Issuer are and have been conducted
at all times in compliance with the money laundering statutes of applicable
jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any
applicable governmental agency and no action, suit or proceeding by or before
any court or governmental agency, authority or body or any arbitrator involving
any of the Issuer with respect thereto is pending or, to the best knowledge of
the Issuer, threatened.
18
3.2 Other Representations and
Warranties Relating to the PRC by the Issuer.
(a) The
constitutional documents and certificates and related material contracts of the
Issuer and the Issuer’s subsidiaries have been established under the laws of the
PRC for purposes of this Section 3.2 (sometimes referred to as a “PRC Company”) and are
valid and have been duly approved or registered (as applicable) by competent PRC
governmental authorities.
(b) All
material consents, approvals, authorizations or licenses requisite under PRC law
for the due and proper establishment and operation of each PRC Company have been
duly obtained from the relevant PRC governmental authorities and are in full
force and effect.
(c) All
filings and registrations with the PRC governmental authorities required in
respect of each of the PRC Companies and their respective operations including,
without limitation, the registrations with the Ministry of Commerce, the State
Administration of Industry and Commerce, the State Administration for Foreign
Exchange, tax bureau and customs authorities have been duly completed in
accordance with the relevant PRC rules and regulations.
(d) The
Issuer has complied with all relevant PRC laws and regulations regarding the
contribution and payment of its registered share capital, the payment schedule
of which has been approved by the relevant PRC government
authorities. There are no outstanding rights of, or commitments made
by, the Issuer to sell any equity interest in any PRC Company, or by any of the
other PRC Company’s shareholders to sell any equity interest in such other PRC
the Issuer. To the extent that any controlling shareholder of the Issuer or any
Subsidiary is subject to or under the jurisdiction of Circular 75 issued by the
PRC State Administration of Foreign Exchange on October 21, 2005, including any
amendment, implementing rules, or official interpretation thereof or any
replacement, successor or alternative legislation having the same subject matter
thereof (collectively “Circular 75”), each
of the Issuer and its Subsidiaries and any controlling shareholder represents
and warrants to the Purchaser that it shall fully comply in all respects with
Circular 75 and any related requirement of law, including without limitation,
the completion of any applicable foreign exchange registration, settlement or
remittance requirement therein within 90 days of the Closing.
(e) The
Issuer is not in receipt of any letter or notice from any relevant PRC
governmental authority notifying it of revocation of any licenses or
qualifications issued to it or any subsidy granted to it by any PRC governmental
authority for non-compliance with the terms thereof or with applicable PRC laws,
or the need for compliance or remedial actions in respect of the activities
carried out by the Issuer.
19
(f) The
Issuer has conducted its business activities within the permitted scope of
business or has otherwise operated its business in compliance with all relevant
legal requirements and with all requisite licenses and approvals granted by
competent PRC governmental authorities.
(g) As
to licenses, approvals and government grants and concessions requisite or useful
for the conduct of any part of the PRC, the Issuer’s business which are subject
to periodic renewal, the Issuer has no knowledge of any grounds on which such
requisite renewals will not be granted by the relevant PRC governmental
authorities.
(h) With
regard to employment and staff or labor, each of the Issuer has complied with
all applicable PRC laws and regulations in all material respects, including
without limitation, laws and regulations pertaining to welfare funds, social
benefits, medical benefits, insurance, retirement benefits, pensions or the
like.
3.3 Representations and
Warranties of the Purchasers. Each Purchaser, for itself and
for no other Purchaser hereby, represents and warrants as of the date hereof and
as of the Closing Date to the Issuer as follows:
(a) Organization;
Authority. Such Purchaser is an entity duly organized, validly
existing and in good standing under the laws of the jurisdiction of its
organization with full right, corporate or partnership power and authority to
enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations hereunder and
thereunder. The execution and delivery of the Transaction Documents
and performance by such Purchaser of the transactions contemplated by the
Transaction Documents have been duly authorized by all necessary corporate or
similar action on the part of such Purchaser. Each Transaction
Document to which it is a party has been duly executed by such Purchaser, and
when delivered by such Purchaser in accordance with the terms hereof, will
constitute the valid and legally binding obligation of such Purchaser,
enforceable against it in accordance with its terms, except (i) as limited by
general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting
enforcement of creditors’ rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable
remedies and (iii) insofar as indemnification and contribution provisions may be
limited by applicable law.
(b) Own
Account. Such Purchaser understands that the Securities are
“restricted securities” and have not been registered under the Securities Act or
any applicable state securities law and is acquiring the Securities as principal
for its own account and not with a view to or for distributing or reselling such
Securities or any part thereof in violation of the Securities Act or any
applicable state securities law, has no present intention of distributing any of
such Securities in violation of the Securities Act or any applicable state
securities law and has no direct or indirect arrangement or understandings with
any other persons to distribute or regarding the distribution of such Securities
(this representation and warranty not limiting such Purchaser’s right to sell
the Securities pursuant to the Registration Statement or otherwise in compliance
with applicable federal and state securities laws) in violation of the
Securities Act or any applicable state securities law. Such Purchaser
is acquiring the Securities hereunder in the ordinary course of its
business.
20
(c) Purchaser
Status. At the time such Purchaser was offered the Securities,
it was, and at the date hereof it is, and on each date on which it exercises any
Warrants it will be either: (i) an “accredited investor” as defined in Rule
501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a
“qualified institutional buyer” as defined in Rule 144A(a) under the Securities
Act. Such Purchaser is not required to be registered as a
broker-dealer under Section 15 of the Exchange Act.
(d) Experience of Such
Purchaser. Such Purchaser, either alone or together with its
representatives, has such knowledge, sophistication and experience in business
and financial matters so as to be capable of evaluating the merits and risks of
the prospective investment in the Securities, and has so evaluated the merits
and risks of such investment. Such Purchaser is able to bear the
economic risk of an investment in the Securities and, at the present time, is
able to afford a complete loss of such investment.
(e) General
Solicitation. Such Purchaser is not purchasing the Securities
as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media
or broadcast over television or radio or presented at any seminar or any other
general solicitation or general advertisement.
(f) Short
Sales. Other than consummating the transactions contemplated
hereunder, such Purchaser has not directly or indirectly, nor has any Person
acting on behalf of or pursuant to any understanding with such Purchaser,
executed any purchases or sales, including Short Sales, of the securities
of the Issuer during the period commencing from the time that such Purchaser
first received a term sheet (written or oral) from the Issuer or any other
Person representing the Issuer setting forth the material terms of the
transactions contemplated hereunder until the date hereof (“Discussion
Time”). Notwithstanding the foregoing, in the case of a
Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser’s assets and the portfolio
managers have no direct knowledge of the investment decisions made by the
portfolio managers managing other portions of such Purchaser’s assets, the
representation set forth above shall only apply with respect to the portion of
assets managed by the portfolio manager that made the investment decision to
purchase the Securities covered by this Agreement.
(g) Investment
Intent. The Purchaser is not acquiring the Securities with a
view to any distribution thereof that would violate the Securities Act or the
securities laws of any state of the United States or any other applicable
jurisdiction.
21
(h) Resale
Restrictions. The Purchaser (A) agrees that it will not offer,
sell or otherwise transfer any of the Securities nor, unless in compliance with
the Securities Act or as allowed under Regulation D, engage in hedging
transactions involving such securities, on or prior to (x) the date which is 40
days (in the case of the Common Stock) or six months (in the case of the
Warrants and the Warrant Shares) after the later of the date of the commencement
of the offering and the date of original issuance (or of any predecessor of any
Security proposed to be transferred by the Purchaser) and (y) such later date,
if any, as may be required by applicable law, except (a) to the Issuer, (b)
pursuant to a registration statement that has been declared effective under the
Securities Act, (c) pursuant to offers and sales to Persons who are not “U.S.
Persons” (within the meaning of Regulation S) that occur outside the United
States within the meaning of Regulation S or (d) pursuant to any other available
exemption from the registration requirements of the Securities Act, and (B)
agrees that it will give to each person to whom such Security is transferred a
notice substantially to the effect of this paragraph. The
Purchaser acknowledges that the Securities are “restricted securities” as
defined in Rule 144 under the Securities Act and subject to resale restrictions
during the period set forth in Rule 144.
ARTICLE
IV.
POST
CLOSING COVENANTS AND OTHER AGREEMENTS OF THE PARTIES
4.1 Transfer
Restrictions.
(a) The Securities may only be disposed
of in compliance with state and federal securities laws. In
connection with any transfer of Securities other than pursuant to an effective
registration statement, Regulation S or Rule 144, to the Issuer or to an
Affiliate of a Purchaser or in connection with a pledge as contemplated in
Section 4.1(c), the Issuer may require the transferor thereof to provide to the
Issuer an opinion of counsel selected by the transferor and reasonably
acceptable to the Issuer, the form and substance of which opinion shall be
reasonably satisfactory to the Issuer, to the effect that such transfer does not
require registration of such transferred Securities under the Securities
Act. As a condition of transfer, any such transferee shall agree in
writing to be bound by the terms of this Agreement and shall have the rights of
a Purchaser under this Agreement and the Registration Rights
Agreement.
(b) The Purchasers agree to
the imprinting, so long as is required by this Section 4.1, of a
legend on any of the Securities in the following form:
THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
ISSUER. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.
22
(c) The
Issuer acknowledges and agrees that a Purchaser may from time to time pledge
pursuant to a bona fide margin agreement with a registered broker-dealer or
grant a security interest in some or all of the Securities to a financial
institution that is an “accredited investor” as defined in Rule 501(a) under the
Securities Act and who agrees to be bound by the provisions of this Agreement
and the Registration Rights Agreement and, if required under the terms of such
arrangement, such Purchaser may transfer pledged or secured Securities to the
pledged or secured parties. Such a pledge or transfer would not be
subject to approval of the Issuer and no legal opinion of legal counsel of the
pledge, secured party or pledgor shall be required in connection
therewith. Further, no notice shall be required of such
pledge. At the appropriate Purchaser’s expense, the Issuer will
execute and deliver such reasonable documentation as a pledge or secured party
of Securities may reasonably request in connection with a pledge or transfer of
the Securities, including, if the Securities are subject to registration
pursuant to the Registration Rights Agreement, the preparation and filing of any
required prospectus supplement under Rule 424(b)(3) under the Securities Act or
other applicable provision of the Securities Act to appropriately amend the list
of selling stockholders thereunder.
(d) Certificates
evidencing the Underlying Shares shall not contain any legend (including the
legend set forth in Section 4.1(b) hereof): (i) while a registration statement
(including the Registration Statement) covering the resale of such security is
effective under the Securities Act, or (ii) following any sale of such
Underlying Shares pursuant to Rule 144, or (iii) if such Underlying Shares are
eligible for sale under Rule 144 or (iv) if such legend is not required under
applicable requirements of the Securities Act (including judicial
interpretations and pronouncements issued by the staff of the Commission). The
Issuer shall cause its counsel to issue a legal opinion to the Transfer Agent
promptly after the Effective Date if required by the Transfer Agent to effect
the removal of the legend hereunder. If all or any portion of a
Warrant is exercised at a time when there is an effective registration statement
to cover the resale of the Underlying Shares, or if such Underlying Shares may
be sold under Rule 144 or if such legend is not otherwise required under
applicable requirements of the Securities Act (including judicial
interpretations and pronouncements issued by the staff of the Commission) then
such Underlying Shares shall be issued free of all legends. The
Issuer agrees that following the Effective Date or at such time as such legend
is no longer required under this Section 4.1(d), it will, no later than three
Trading Days following the delivery by a Purchaser to the Issuer or the Transfer
Agent of a certificate representing Underlying Shares, as applicable, issued
with a restrictive legend (such third Trading Day, the “Legend Removal
Date”), deliver or cause to be delivered to such Purchaser a certificate
representing such shares that is free from all restrictive and other
legends. The Issuer may not make any notation on its records or give
instructions to the Transfer Agent that enlarge the restrictions on transfer set
forth in this Section. Certificates for Underlying Shares subject to
legend removal hereunder shall be transmitted by the Transfer Agent to the
Purchaser by crediting the account of the Purchaser’s prime broker with the
Depository Trust Company System as directed by such Purchaser.
23
(e) In
addition to such Purchaser’s other available remedies, the Issuer shall pay to a
Purchaser, in cash, as partial liquidated damages and not as a penalty, for each
$1,000 of Underlying Shares (based on the VWAP of the Common Stock on the date
such Securities are submitted to the Transfer Agent) delivered for removal of
the restrictive legend and subject to Section 4.1(d), $5.00 per Trading Day
(increasing to $10.00 per Trading Day 45 Trading Days after such damages have
begun to accrue) for each Trading Day after the Legend Removal Date until such
certificate is delivered without a legend. Nothing herein shall limit
such Purchaser’s right to pursue actual damages for the Issuer’s failure to
deliver certificates representing any Securities as required by the Transaction
Documents, and such Purchaser shall have the right to pursue all remedies
available to it at law or in equity including, without limitation, a decree of
specific performance and/or injunctive relief.
(f) Each
Purchaser, severally and not jointly with the other Purchasers, agrees that such
Purchaser will sell any Securities pursuant to either the registration
requirements of the Securities Act, including any applicable prospectus delivery
requirements, or an exemption therefrom, and that if Securities are sold
pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the
restrictive legend from certificates representing Securities as set forth in
this Section 4.1 is predicated upon the Issuer’s reliance upon this
understanding.
4.2 Acknowledgment of
Dilution. The Issuer acknowledges that the issuance of the
Underlying Shares may result in dilution of the outstanding shares of Common
Stock, which dilution may be substantial under certain market
conditions. The Issuer further acknowledges that its obligations
under the Transaction Documents, including without limitation its obligation to
issue the Underlying Shares pursuant to the Transaction Documents, are
unconditional and absolute and not subject to any right of set off,
counterclaim, delay or reduction, regardless of the effect of any such dilution
or any claim the Issuer may have against any Purchaser and regardless of the
dilutive effect that such issuance may have on the ownership of the other
stockholders of the Issuer.
4.3 Furnishing of
Information. So long as the Purchaser owns Securities, the
Issuer covenants to timely file (or obtain extensions in respect thereof and
file within the applicable grace period) all reports required to be filed by the
Issuer after the date hereof pursuant to the Exchange Act. As
long as any Purchaser owns Securities, if the Issuer is not required to file
reports pursuant to the Exchange Act, it will prepare and furnish to the
Purchasers and make publicly available in accordance with Rule 144(c) such
information as is required for the Purchasers to sell the Securities under Rule
144. The Issuer further covenants that it will take such further action as any
holder of Securities may reasonably request, to the extent required from time to
time to enable such Person to sell such Securities without registration under
the Securities Act within the requirements of the exemption provided by Rule
144.
24
4.4 Integration. The
Issuer shall not sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that would be integrated with the offer or sale of the Securities to the
Purchasers in a manner that would require the registration under the Securities
Act of the sale of the Securities to the Purchasers or that would be integrated
with the offer or sale of the Securities for purposes of the rules and
regulations of any Trading Market.
4.5 Non-Public
Information. Except with respect to the material terms and
conditions of the transactions contemplated by the Transaction Documents, the
Issuer covenants and agrees that neither it nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information
that the Issuer believes constitutes material non-public information, unless
prior thereto such Purchaser shall have executed a written agreement regarding
the confidentiality and use of such information. The Issuer
understands and confirms that each Purchaser shall be relying on the foregoing
covenant in effecting transactions in securities of the Issuer.
4.6 Listing. The
Issuer shall use its best efforts to have its Common Stock listed with the
Nasdaq Stock Market, the American Stock Exchange or any other national exchange
as soon as possible, shall use all commercially reasonable efforts to comply
with the listing requirements and shall file any and all applications with the
Nasdaq Stock Market, the American Stock Exchange or such other national exchange
to obtain a listing for its Common Stock by the earlier of (a) the closing of
the Issuer’s the next financing or (b) August 31, 2009 and, assuming the Common
Stock is accepted for listing, shall use its best efforts to maintain such
listing for so long as the Purchasers hold shares of Common Stock.
4.7 Securities Laws Disclosure;
Publicity. The Issuer and each Purchaser shall consult with
each other in issuing any other press releases with respect to the transactions
contemplated hereby, and neither the Issuer nor any Purchaser shall issue any
such press release or otherwise make any such public statement without the prior
consent of the Issuer, with respect to any press release of any Purchaser, or
without the prior consent of each Purchaser, with respect to any press release
of the Issuer, which consent shall not unreasonably be withheld or delayed,
except if such disclosure is required by law, in which case the disclosing party
shall promptly provide the other party with prior notice of such public
statement or communication. Notwithstanding the foregoing, the Issuer
shall not publicly disclose the name of any Purchaser, or include the name of
any Purchaser in any filing with the Commission or any regulatory agency or
Trading Market, without the prior written consent of such Purchaser, except (i)
as required by federal securities law in connection with any registration
statement contemplated by the Registration Rights Agreement and (ii) to the
extent such disclosure is required by law or Trading Market regulations, in
which case the Issuer shall provide the Purchasers with prior notice of such
disclosure permitted under this clause (ii).
4.8 Shareholder Rights
Plan. No claim will be made or enforced by the Issuer or, with
the consent of the Issuer, any other Person, that any Purchaser is an “Acquiring
Person” under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover
plan or arrangement in effect or hereafter adopted by the Issuer, or that any
Purchaser could be deemed to trigger the provisions of any such plan or
arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Issuer and the Purchasers.
25
4.9 Use of
Proceeds. The Issuer shall use the net proceeds from the
sale of the Securities hereunder for working capital purposes.
4.10 Indemnification of
Purchasers. Subject to the provisions of this Section
4.10, the Issuer will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other
Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title), each Person who
controls such Purchaser (within the meaning of Section 15 of the Securities Act
and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a
functionally equivalent role of a Person holding such titles notwithstanding a
lack of such title or any other title) of such controlling person (each, a
“Purchaser
Party”) harmless from any and all losses, liabilities, obligations,
claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys’ fees and
costs of investigation that any such Purchaser Party may suffer or incur as a
result of or relating to (a) any breach of any of the representations,
warranties, covenants or agreements made by the Issuer in this Agreement or in
the other Transaction Documents or (b) any action instituted against a Purchaser
in any capacity, or any of them or their respective Affiliates, by any
stockholder of the Issuer who is not an Affiliate of such Purchaser, with
respect to any of the transactions contemplated by the Transaction Documents
(unless such action is based upon a breach of such Purchaser’s representations,
warranties or covenants under the Transaction Documents or any agreements or
understandings such Purchaser may have with any such stockholder or any
violations by the Purchaser of state or federal securities laws or any conduct
by such Purchaser which constitutes fraud, gross negligence, willful misconduct
or malfeasance). If any action shall be brought against any Purchaser
Party in respect of which indemnity may be sought pursuant to this Agreement,
such Purchaser Party shall promptly notify the Issuer in writing, and the Issuer
shall have the right to assume the defense thereof with counsel of its own
choosing reasonably acceptable to the Purchaser Party. Any Purchaser
Party shall have the right to employ separate counsel in any such action and
participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Purchaser Party except to the extent that (i)
the employment thereof has been specifically authorized by the Issuer in
writing, (ii) the Issuer has failed after a reasonable period of time to assume
such defense and to employ counsel or (iii) in such action there is, in the
reasonable opinion of such separate counsel, a material conflict on any material
issue between the position of the Issuer and the position of such Purchaser
Party, in which case the Issuer shall be responsible for the reasonable fees and
expenses of no more than one such separate counsel. The Issuer will
not be liable to any Purchaser Party under this Agreement (i) for any settlement
by a Purchaser Party effected without the Issuer’s prior written consent, which
shall not be unreasonably withheld or delayed; or (ii) to the extent, but only
to the extent that a loss, claim, damage or liability is attributable to any
Purchaser Party’s breach of any of the representations, warranties, covenants or
agreements made by such Purchaser Party in this Agreement or in the other
Transaction Documents.
26
4.11 Reservation of
Securities.
(a) The
Issuer shall maintain a reserve from its duly authorized shares of Common Stock
for issuance pursuant to the Transaction Documents in such amount as may be
required to fulfill its obligations in full under the Transaction
Documents.
(b) If,
on any date, the number of authorized but unissued (and otherwise unreserved)
shares of Common Stock is less than the required minimum on such date, then the
Board of Directors of the Issuer shall use commercially reasonable efforts to
amend the Issuer’s certificate or articles of incorporation to increase the
number of authorized but unissued shares of Common Stock, as soon as possible
and in any event not later than the 75th day
after such date.
4.12 Participation in Future
Financing.
(a) From the
date hereof until the second anniversary of the Effective Date upon any issuance
by the Issuer or any of its Subsidiaries of Common Stock, Common Stock
Equivalents or debt security (a “Subsequent
Financing”), each Purchaser shall have the right of first refusal to
participate in the Subsequent Financing on the same terms, conditions and price
provided for in the Subsequent Financing.
(b) At least
ten (10) Trading Days prior to the closing of the Subsequent Financing, the
Issuer shall deliver to each Purchaser a written notice of its intention to
effect a Subsequent Financing (“Pre-Notice”), which
Pre-Notice shall ask such Purchaser if it wants to review the details of such
financing (such additional notice, a “Subsequent Financing
Notice”). Upon the request of a Purchaser, and only upon a
request by such Purchaser, for a Subsequent Financing Notice, the Issuer shall
promptly, but no later than one Trading Day after such request, deliver a
Subsequent Financing Notice to such Purchaser. The Subsequent
Financing Notice shall describe in reasonable detail the proposed terms of such
Subsequent Financing, the amount of proceeds intended to be raised thereunder
and the Person or Persons through or with whom such Subsequent Financing is
proposed to be effected and shall include a term sheet or similar document
relating thereto as an attachment. The Subsequent Financing Notice
shall also include an analysis or description of the effect of such Subsequent
Financing upon the exercise price of the Warrants and the capitalization of the
Issuer.
(c) Any
Purchaser desiring to participate in such Subsequent Financing must provide
written notice to the Issuer by not later than 5:30 p.m. (New York City time) on
the 10th Trading
Day after all of the Purchasers have received the Pre-Notice that the Purchaser
is willing to participate in the Subsequent Financing, the amount of the
Purchaser’s participation, and that the Purchaser has such funds ready, willing,
and available for investment on the terms set forth in the Subsequent Financing
Notice. If the Issuer receives no notice from a Purchaser as of such
10th
Trading Day, such Purchaser shall be deemed to have notified the Issuer that it
does not elect to participate.
27
(d) If by
5:30 p.m. (New York City time) on the 10th Trading
Day after all of the Purchasers have received the Pre-Notice, notifications by
the Purchasers of their willingness to participate in the Subsequent Financing
(or to cause their designees to participate) is, in the aggregate, less than the
total amount of the Subsequent Financing, then the Issuer may effect the
remaining portion of such Subsequent Financing on the terms and with the Persons
set forth in the Subsequent Financing Notice.
(e) The
Issuer must provide the Purchasers with a second Subsequent Financing Notice,
and the Purchasers will again have the right of participation set forth above in
this Section 4.12, if the Subsequent Financing subject to the initial Subsequent
Financing Notice is not consummated for any reason on the terms set forth in
such Subsequent Financing Notice within 60 Trading Days after the date of the
initial Subsequent Financing Notice.
(f) Notwithstanding
the foregoing, this Section 4.12 shall not apply in respect of an issuance of
(a) shares of Common Stock or options to employees, officers or directors of the
Issuer pursuant to any stock or option plan duly adopted for such purpose by a
majority of the non-employee members of the Board of Directors of the Issuer or
a majority of the members of a committee of non-employee directors established
by the Board of Directors, provided, however, in no event shall the number of
shares reserved under any such plan or issued under such plan or issued to
employees, officers, directors or officers of the Issuer exceed a number of
shares equal to 5% of the issued and outstanding shares of Common Stock of the
Issuer on the date hereof or; (b) securities upon the exercise or exchange of or
conversion of any Securities issued hereunder and/or other securities
exercisable or exchangeable for or convertible into shares of Common Stock
issued and outstanding on the date of this Agreement, provided that such
securities have not been amended since the date of this Agreement to increase
the number of such securities or to decrease the exercise, exchange or
conversion price of such securities.
4.13 Subsequent Equity
Sales.
(a) From the
date hereof until 180 days after the Effective Date, neither the Issuer nor any
Subsidiary shall issue shares of Common Stock or Common Stock Equivalents; provided, however, the 180 day
period set forth in this Section 4.13 shall be extended for the number of
Trading Days during such period in which following the Effective
Date, the Registration Statement is not effective or the prospectus included in
the Registration Statement may not be used by the Purchasers for the resale of
the Underlying Shares.
(b) From and
after the Effective Date the Issuer shall not issue inconnection with an
acquisition transaction (whether in one transaction or a series
oftransactions (and regardless of the structure of any such transaction,
including, without limitation, a purchase of securities of the to be acquired
entity, a purchase or assets or a joint venture) or the purchase) shares of its
Common Stock (or securities convertible into Common Stock) equal to or in excess
of 20% of the shares of Common Stock outstanding on the date hereof without the
prior written consent of the Purchaser, which consent shall not be unreasonably
withheld.
28
4.14 Equal Treatment of
Purchasers. No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of any
of the Transaction Documents unless the same consideration is also offered to
all of the parties to the Transaction Documents. For clarification
purposes, this provision constitutes a separate right granted to each Purchaser
by the Issuer and negotiated separately by each Purchaser, and is intended for
the Issuer to treat the Purchasers as a class and shall not in any way be
construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.
4.15 Short
Sales. Each Purchaser severally and not jointly with the other
Purchasers, covenants that neither it nor any Affiliate acting on its behalf or
pursuant to any understanding with it will execute any Short Sales during the
period commencing at the Discussion Time and ending at the eighteen month
anniversary of the Closing Date. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate
portfolio managers manage separate portions of such Purchaser’s assets and the
portfolio managers have no direct knowledge of the investment decisions made by
the portfolio managers managing other portions of such Purchaser’s assets, the
covenant set forth above shall only apply with respect to the portion of assets
managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.
ARTICLE
V.
PROPERTIES
AND ADVANCES
5.1 Leases.
(a) Each
of the Issuer and Chairman covenant and agree with Purchasers that the stores
listed in this Section 5.1(a) owned by Chairman shall be leased to the Issuer
pursuant to binding written lease agreements containing terms no less favorable
to the Issuer than the Issuer could have negotiated in an arm’s length
transaction with a motivated landlord, including substantially the following
terms:
(i) Xxxxxx
Xxxxx Queen Demonstration Beauty Parlor: 5 years from January 1, 2008 through
December 31, 2012, for $47,300 per year, prepaid for 1 year plus an option for
additional 5 years at no more than $55,000 per year.
(ii) Harbin
Queen Beauty Demonstration Center: 5 years from January 1, 2008 through December
31, 2012 for $20,300 per year, prepaid for 1 year plus an option for additional
5 years at no more than $24,000 per year.
(b) The
Issuer covenants and agrees with Purchasers that the following stores with
leases expiring in December 2008 owned by third parties shall be extended
pursuant to binding written lease agreements containing terms no less favorable
to the Issuer than the Issuer could have negotiated in an arm’s length
transaction with a motivated landlord, including substantially the following
terms:
29
Store
shall have signed additional terms as follows:
|
(i)
Harbin Huang Emperor & Golden Gym Club Co., Ltd.: 5 years, at $85,100,
prepaid 1 year, ending December
2013.
|
(c) The
following stores shall be leased to the Issuer, subject to cancellation if and
when a more desirable location is found:
|
(i) Harbin
Queen Beauty Demonstration Center Kunlun Branch: 5 years ending December
2013 at no more than $13,000 per year, prepaid 1
year.
|
|
(ii)
Harbin Queen Beauty Demonstration Center Branch: 5 years ending December
2013 at no more than $40,000 per year, prepaid 1
year.
|
The
dollar amounts quoted above use an assumed exchange rate of 1:7.4 between US
Dollars (“USD”)
and Renminbi (“RMB”). The
actual dollar amount quoted above shall be adjusted according to the actual
exchange rate between USD and RMB at the time of execution of the
lease.
5.2 Office
Building. The Issuer will purchase its current office building
during fiscal year 2008 for an amount not to exceed $1.65
million. The purchase price for such office building will be funded
solely by the return of funds identified by the Balance Sheet item “Advance to
Employee”. In the event the office building is not purchased, the
$1.65 million Advance to Employee shall be immediately repaid, such repayment is
unconditionally guaranteed by the Chairman.
5.3 Liquidated
Damages. In the Event the Issuer is unable to extend any lease
set forth in Section 5.1 for a minimum of 5 years by October 1, 2008, then
within 30 days of such date, the Issuer shall issue to the Purchasers 50,000
additional shares of Common Stock per lease (with registration rights comparable
to the Securities issued on the Closing Date) pro rata to the Securities issued
to Purchasers on the Closing Date, as liquidated damages for such breach and not
as a penalty. The amount of shares issuable under this Section 5.3
shall be appropriately adjusted for any stock split, stock dividend or other
recapitalization after the Closing Date.
5.4 Certain
Payments.
(a) Advances
to suppliers shall never exceed (i) $3 million at any time for Fiscal Year 2008,
or (ii) $4 million at any time for Fiscal Year 2009.
(b) Advances
to Affiliates or employees of the Issuer shall never exceed for Fiscal Years
2008 or 2009 (i) $100,000 to any single Person, or (ii) $500,000 in the
aggregate.
30
(c) Within
three Trading Days of the end of Fiscal Years 2008 and 2009, respectively, for
each breach of the provisions of Section 5.4(a), the Issuer shall
issue to the Purchasers 50,000 additional shares of Common Stock per each $1
million of such breach and for each breach of the provisions of Section
5.4(b), the Issuer shall issue to the Purchasers 50,000 additional
shares of Common Stock per each $100,000 of such breach (in each case, with
registration rights comparable to the shares issued on the Closing Date) pro
rata to the shares issued to Purchasers on the Closing Date, as liquidated
damages for such breach and not as a penalty. The amount of shares
issuable under this Section 5.4 shall be appropriately adjusted for any stock
split, stock dividend or other recapitalization after the Closing
Date.
ARTICLE
VI.
MISCELLANEOUS
6.1 Termination.
This Agreement may be terminated by any Purchaser, as to such Purchaser’s
obligations hereunder only and without any effect whatsoever on the obligations
between the Issuer and the other Purchasers, by written notice to the other
parties, if the Closing has not been consummated on or before April 30, 2008;
provided, however, that such
termination will not affect the right of any party to xxx for any breach by the
other party (or parties).
6.2 Fees and Expenses; Breakup
Fees.
(a) At
the Closing, the Issuer will reimburse the Purchasers the sum of up to $25,000,
for their legal fees and expenses, none of which has been paid prior to the
Closing, and such other expenses as are listed on the Disbursement Schedule set
forth in Annex
A. Except as expressly set forth in the Transaction Documents
to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred
by such party incident to the negotiation, preparation, execution, delivery and
performance of this Agreement. The Issuer shall pay all transfer
agent fees, stamp taxes and other taxes and duties levied in connection with the
delivery of any Securities to the Purchasers.
(b) The
Purchasers will be entitled to a fee in the amount of $200,000 in the event that
(i) the Issuer or any Affiliate accepts or approves any proposal that provides
equity or debt financing to it prior to the Closing Date (any such proposal, an
“Alternative
Transaction”), or (ii) the Issuer fails to satisfy any of the closing
conditions set forth in Section 2.3(b), and such conditions have not been waived
in writing by each of the Purchasers.
(c) The Issuer will not be obligated to pay the fee set
forth in Section 6.2(b) if the Purchasers terminate this Agreement for any
reason other than as a result of (i) the Issuer’s willful failure to satisfy any
of the closing conditions set forth in Section 2.3(b) for the purposes of
delaying or precluding the closing of the transaction; or (ii) the Issuer’s
failure to adhere to comply with the requirements of Section 2.1 on the Closing
Date. In the event the Issuer accepts or approves an Alternative Transaction,
the fee set forth in Section 6.2(b) shall be due and payable
immediately.
31
(d) To
the maximum extent permitted by applicable law, in no event will the Purchasers
be liable for any punitive damages arising out of this Agreement.
6.3 Entire
Agreement. The Transaction Documents, together with the
exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and supersede all prior agreements and
understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and
schedules.
6.4 Notices. Any
and all notices or other communications or deliveries required or permitted to
be provided hereunder shall be in writing and shall be deemed given and
effective on the earliest of (a) the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile number set forth on
the signature pages attached hereto prior to 5:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number set
forth on the signature pages attached hereto on a day that is not a Trading Day
or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second
Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and
communications shall be as set forth on the signature pages attached
hereto.
6.5 Amendments;
Waivers. No provision of this Agreement may be waived,
modified, supplemented or amended except in a written instrument signed, in the
case of an amendment, by the Issuer and the Purchasers of at least 66% principal
amount of Securities still held by Purchasers or, in the case of a waiver, by
the party against whom enforcement of any such waived provision is
sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any
other provision, condition or requirement hereof, nor shall any delay or
omission of any party to exercise any right hereunder in any manner impair the
exercise of any such right.
6.6 Headings. The
headings herein are for convenience only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions
hereof.
6.7 Successors and
Assigns. This Agreement shall be binding upon and inure to the
benefit of the parties and their successors and permitted
assigns. The Issuer may not assign this Agreement or any rights or
obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights
under this Agreement to any Person to whom such Purchaser assigns or transfers
any Securities, provided that such transferee agrees in writing to be bound,
with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the “Purchasers.”
6.8 No Third-Party
Beneficiaries. This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns and is
not for the benefit of, nor may any provision hereof be enforced by, any other
Person, except as otherwise set forth in Section 4.10.
32
6.9 Governing
Law. All questions concerning the construction, validity,
enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of
New York, without regard to the principles of conflicts of law
thereof. Each party agrees that all legal proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by
this Agreement and any other Transaction Documents (whether brought against a
party hereto or its respective affiliates, directors, officers, shareholders,
employees or agents) shall be commenced exclusively in the City of
New York, New York and shall be arbitrated in accordance with the rules of the
International Chamber of Commerce before three (3) arbitrators and otherwise
held in accordance with its rules. Each party shall choose one
arbitrator and the two arbitrators shall choose the third. The third
arbitrator so chosen shall have a background in either corporate finance,
banking or law. The arbitration shall be conducted in the English language and
the arbitration award shall include the allocation of costs and expenses among
the parties. The arbitration ruling shall be final and binding. Each party
hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of
delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any other manner
permitted by law. Any ruling by the arbitration panel shall be
binding and non appealable.
6.10 Survival. The
representations and warranties shall survive the Closing and the delivery of the
Securities for the applicable statue of limitations.
6.11 Execution. This
Agreement may be executed in two or more counterparts, all of which when taken
together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the
other party, it being understood that both parties need not sign the same
counterpart. In the event that any signature is delivered by
facsimile transmission or by e-mail delivery of a “.pdf” format data file, such
signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if
such facsimile or “.pdf” signature page were an original thereof.
6.12 Severability. If any
term, provision, covenant or restriction of this Agreement is held by a court of
competent jurisdiction to be invalid, illegal, void or unenforceable, the
remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired
or invalidated, and the parties hereto shall use their commercially reasonable
efforts to find and employ an alternative means to achieve the same or
substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the
intention of the parties that they would have executed the remaining terms,
provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.
33
6.13 Rescission and Withdrawal
Right. Notwithstanding anything to the contrary contained in
(and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option
under a Transaction Document and the Issuer does not timely perform its related
obligations within the periods therein provided, then such Purchaser may rescind
or withdraw, in its sole discretion from time to time upon written notice to the
Issuer, any relevant notice, demand or election in whole or in part without
prejudice to its future actions and rights; provided, however, in the case
of exercise of a Warrant, the Purchaser shall be required to return any shares
of Common Stock delivered in connection with any such rescinded exercise
notice.
6.14 Replacement of
Securities. If any certificate or instrument evidencing any
Securities is mutilated, lost, stolen or destroyed, the Issuer shall issue or
cause to be issued in exchange and substitution for and upon cancellation
thereof (in the case of mutilation), or in lieu of and substitution therefor, a
new certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Issuer of such loss, theft or destruction. The
applicant for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs (including customary indemnity)
associated with the issuance of such replacement Securities.
6.15 Remedies. In
addition to being entitled to exercise all rights provided herein or granted by
law, including recovery of damages, each of the Purchasers and the Issuer will
be entitled to specific performance under the Transaction
Documents. The parties agree that monetary damages may not be
adequate compensation for any loss incurred by reason of any breach of
obligations contained in the Transaction Documents and hereby agrees to waive
and not to assert in any action for specific performance of any such obligation
the defense that a remedy at law would be adequate.
6.16 Payment Set Aside. To
the extent that the Issuer makes a payment or payments to any Purchaser pursuant
to any Transaction Document or a Purchaser enforces or exercises its rights
thereunder, and such payment or payments or the proceeds of such enforcement or
exercise or any part thereof are subsequently invalidated, declared to be
fraudulent or preferential, set aside, recovered from, disgorged by or are
required to be refunded, repaid or otherwise restored to the Issuer, a trustee,
receiver or any other person under any law (including, without limitation, any
bankruptcy law, state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part thereof
originally intended to be satisfied shall be revived and continued in full force
and effect as if such payment had not been made or such enforcement or setoff
had not occurred.
6.17 Independent Nature of
Purchasers’ Obligations and Rights. The obligations of each
Purchaser under any Transaction Document are several and not joint with the
obligations of any other Purchaser, and no Purchaser shall be responsible in any
way for the performance or non-performance of the obligations of any other
Purchaser under any Transaction Document. Nothing contained herein or
in any other Transaction Document, and no action taken by any Purchaser pursuant
thereto, shall be deemed to constitute the Purchasers as a partnership, an
association, a joint venture or any other kind of entity, or create a
presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the
Transaction Documents. Each Purchaser shall be entitled to
independently protect and enforce its rights, including without limitation the
rights arising out of this Agreement or out of the other Transaction Documents,
and it shall not be necessary for any other Purchaser to be joined as an
additional party in any proceeding for such purpose.
34
6.18 Liquidated
Damages. The Issuer’s obligations to pay any partial
liquidated damages or other amounts owing under the Transaction Documents is a
continuing obligation of the Issuer and shall not terminate until all unpaid
partial liquidated damages and other amounts have been paid notwithstanding the
fact that the instrument or security pursuant to which such partial liquidated
damages or other amounts are due and payable shall have been
canceled.
6.19 Construction. The
parties agree that each of them and/or their respective counsel has reviewed and
had an opportunity to revise the Transaction Documents and, therefore, the
normal rule of construction to the effect that any ambiguities are to be
resolved against the drafting party shall not be employed in the interpretation
of the Transaction Documents or any amendments hereto.
(Signature
Pages Follow)
35
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.
AMERICAN
BUSINESS HOLDINGS,
Inc.
|
Address for
Notice:
|
By:__________________________________________
Name:
Title:
|
000
Xxx Xx Xx Xxxxxx, Xxxxxxx Xxxxxxxx,
Xxxxxx
Xxxx, Xxxxxxxxxxxx Xxxxxxxx,
Zip‐code:
150001, P.R.China
xx000@000.xxx
|
With
a copy to (which shall not constitute notice):
Sichenzia
Xxxx Xxxxxxxx Xxxxxxx LLP
00
Xxxxxxxx, 00xx
Xx.
Xxx
Xxxx, Xxx Xxxx 00000
Fax:
(000) 000-0000
|
|
Xxxx
Xxx
|
000
Xxx Xx Xx Xxxxxx, Xxxxxxx Xxxxxxxx,
Xxxxxx
Xxxx, Xxxxxxxxxxxx Xxxxxxxx,
Zip‐code:
150001, P.R.China
xx000@000.xxx
|
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE
PAGE FOR PURCHASER FOLLOWS]
36
[PURCHASER
SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]
IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement
to be duly executed by their respective authorized signatories as of the date
first indicated above.
|
Name
of Purchaser: GUERRILLA
PARTNERS, LP
|
Signature of Authorized Signatory of
Purchaser: ______________________________________
Name of
Authorized Signatory:
____________________________________________________
Title of
Authorized Signatory:
_____________________________________________________
Email
Address of Purchaser:
______________________________________________________
Facsimile
Number of Purchaser:
___________________________________________________
Address
for Notice of Purchaser:
000 Xxxx
Xxxxxx 0xx Xxxxx, Xxx Xxxx, XX 00000
With a
copy to (which shall not constitute notice):
Xxxxx
Rozynko LLP
000
Xxxxxxxxxx Xxxxxx
Xxxxx
0000
Xxx
Xxxxxxxxx, XX 00000
Fax:
(000) 000-0000
Address
for Delivery of Securities for Purchaser (if not same as above):
Subscription
Amount:
Warrant
Shares:
37
EIN
Number: [PROVIDE
THIS UNDER SEPARATE COVER]
[SIGNATURE
PAGES CONTINUE]
|
Name
of Purchaser: HUA-MEI
21ST CENTURY
PARTNERS
|
Signature of Authorized Signatory of
Purchaser: ______________________________________
Name of
Authorized Signatory:
____________________________________________________
Title of
Authorized Signatory:
_____________________________________________________
Email
Address of Purchaser:
______________________________________________________
Facsimile
Number of Purchaser:
____________________________________________________
Address
for Notice of Purchaser:
000 Xxxx
Xxxxxx 0xx Xxxxx, Xxx Xxxx, XX 00000
Address
for Delivery of Securities for Purchaser (if not same as above):
Subscription
Amount:
Warrant
Shares:
EIN
Number: [PROVIDE
THIS UNDER SEPARATE COVER]
38
[SIGNATURE
PAGES CONTINUE]
Name of
Purchaser: XXXXX
X.XXXX, XX. XXX
Signature of Authorized Signatory of
Purchaser: __________________________________
Name of
Authorized Signatory: Xxxxx X. Xxxx, Xx.
Email
Address of Purchaser: xxxxxxxx@xxx.xxx
Facsimile
Number of Purchaser:
________________________________________________
Address
for Notice of Purchaser:
000 Xxxx
00 Xxxxxx
Xxx Xxxx,
XX 00000
Address
for Delivery of Securities for Purchaser (if not same as above):
Subscription
Amount:
Warrant
Shares:
EIN
Number: [PROVIDE
THIS UNDER SEPARATE COVER]
[SIGNATURE
PAGES CONTINUE]
39
Annex
A
CLOSING
STATEMENT
Schedule
3.1 (m)
Mege
Union:
·
|
Cert
of Approval for establishment of
foreign…
|
·
|
Business
License:
|
·
|
By-law:
|
Queen
Beauty Demo Ctr – Biz Lic
Ctr
Kunlun Branch – Biz Lic
Queen
Beauty Ctr Branch – Biz Lic
Queen
Beauty Demo Ctr – Hygienic Lic
Queen
Beauty Demo Ctr:
By-law
Amendment
to By - law
Huang
Emperor & Golden Gym Club:
Biz
Lic
Hygienic
Lic
By-law
Amendment
to By-law
Daoli
Queen Parlor:
Hygienic
License
Biz
Lic
Queen
Vocational Skill:
Voluntary School
Permit
School
Registration
By-law
Schedule
3.1 (s)
The
Company is represented by Etech Securities, Inc., a member FINRA/SIPC, and has
an
agreement
whereby Etech Securities is receive 7% of the total fund raised in cash and 2%
of the
total
issued and outstanding shares of common stock after the financing.
Schedule
3.1 (dd)
Bagell,
Josephs, Xxxxxx & Company, LLC
000
Xxxxxxxxxx Xxxxx, Xxxxx X
Xxxxxxx,
Xxx Xxxxxx 00000
(Tel)856‐346‐2828
(Fax)856‐396‐0022